Table 2.
The effect of the type of drug resistance or history of TB treatment on the culture conversion rate at month 6 of the two groups
| Indicators | BDQ group (n = 102) | Non-BDQ group (n = 100) | p value | ||
|---|---|---|---|---|---|
| Conversion | Failed to conversion | Conversion | Failed to conversion | ||
| Type of drug resistance (n, %) | |||||
| RR | 3 (100.0) | 0 (0.0) | 4 (80.0) | 1 (20.0) | 1.00 |
| MDR | 65 (87.8) | 9 (12.2) | 50 (73.5) | 18 (26.5) | 0.03* |
| XDR | 22 (88.0) | 3 (12.0) | 18 (66.7) | 9 (33.3) | 0.07 |
| History of TB treatment (n, %) | |||||
| New cases | 10 (90.9) | 1 (9.1) | 6 (75.0) | 2 (25.0) | 0.55 |
| One-time history of TB treatment | 34 (91.9) | 3 (8.1) | 19 (76.0) | 6 (24.0) | 0.17 |
| Two-time history of TB treatment | 27 (84.4) | 5 (15.6) | 31 (81.6) | 7 (18.4) | 0.76 |
| ≥ Three-time history of TB treatment | 19 (86.4) | 3 (13.6) | 16 (55.2) | 13 (44.8) | 0.02* |
| MDR/RR-TB | (n = 77) | (n = 73) | |||
| New cases | 7(100.0) | 0(0.0) | 5 (71.4) | 2 (28.6) | 0.46 |
| One-time history of TB treatment | 30 (90.9) | 3 (9.1) | 15 (71.4) | 6 (28.6) | 0.06 |
| Two-time history of TB treatment | 19 (86.4) | 3 (13.6) | 23 (88.5) | 3 (11.5) | 0.83 |
| ≥ Three-time history of TB treatment | 13 (86.7) | 2 (13.3) | 11 (57.9) | 8 (42.1) | 0.13 |
| XDR-TB | (n = 25) | (n = 27) | |||
| New cases | 3 (75.0) | 1 (25.0) | 1 (100.0) | 0 (0.0) | 1.00 |
| One-time history of TB treatment | 4 (100.0) | 0 (0.0) | 4 (100.0) | 0 (0.0) | – |
| Two-time history of TB treatment | 8 (80.0) | 2 (20.0) | 8 (66.7) | 4 (33.3) | 0.65 |
| ≥ Three-time history of TB treatment | 6 (85.7) | 1 (14.3) | 5 (50.0) | 5 (50.0) | 0.30 |
TB tuberculosis, n number, RR rifampicin-resistant, MDR multidrug-resistant, XDR extensively drug-resistant, BDQ bedaquiline
* the differences had statistical significance (p < 0.05)